Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

National Biocontainment Laboratories Operation Support

by Global Biodefense Staff
April 22, 2015
BSL Level 4 Biodefense Lab (NIAID)

The National Institute for Allergy and Infectious Diseases is soliciting for continued operations support for Biosafety Level 4 (BSL4) facilities at the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) and Boston University.

Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services.

The Laboratories serve as a national resource for efforts in conducting clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAID’s Biodefense Research Agenda and other infectious diseases.

Operations support for the NBLs is provided in the following core areas:

Facility Maintenance and Operation – Provides high containment operational management monitoring and oversight; routine facilities maintenance and upkeep of the physical plant that supports the high containment space including a preventative maintenance plan for all BSL 4 equipment and systems; non-routine emergency repairs of BSL4 equipment and systems; specialized training for facilities personnel working in and around BSL4 space and associated building systems; and community outreach and communications.

BioSecurity – Ensures compliance with all evolving legislation and regulations related to control of select agents and other highly pathogenic agents; devises and directs relevant staff training activities; develops and implements prospective BSL 4 staff screenings and background checks; assists in planning for required biosecurity drills; and manages inventory and access to select agent inventories.

Environmental Health and Biosafety Regulations and Requirements – Provides critical health, safety, and training services; maintains consistency in biosafety and biocontainment practices; provides biosafety theory education and hands-on training; and leads registration, record keeping and administrative activities of the Select Agent program.

Regulatory Compliance – Provides oversight and coordination of all research functions that require compliance with regulatory statutes and guidelines for the purpose of supporting product licensure, promoting accuracy and integrity of any data generated in such studies; conducts relevant GLP compliance training for core directors and key staff; develops and maintains  policies and procedures pertaining to GLP research; and provides advice and oversight for equipment procurement and facility commissioning activities.

Integrated Support Services – Provides specialized services essential to support BSL 4 activities in such cores as veterinary, imaging, insectary, and aerobiology services.  These services are to provide only partial costs of specialized support resources and therefore the NBLs are required to develop and implement cost reimbursement business models that will generate grant or contract support for the direct costs of the research.

To ensure that the NBLs Operations Support Program contributes maximally and effectively to the NIAID biodefense and emerging infectious diseases effort, the overall direction and scope of activities of the Program will be coordinated and monitored by the NIAID Biodefense Facilities Program Office, in collaboration with the NBL Program Directors/Principal Investigators (PDs/PIs).

Further details are available via Funding Opportunity Announcement: RFA-AI-15-009.

Tags: Biosafety

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC